Charity Parkinson’s UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson’s and slow down the progression of the condition. Building on recent discoveries that show a direct link between mitochondrial dysfunction and the loss of dopamine cells, Parkinson’s UK will […]
https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png00Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2019-07-01 08:00:482026-07-31 12:42:27Charity invests £1 million to develop a treatment to slow down progression of Parkinson’s
Charity invests £1 million to develop a treatment to slow down progression of Parkinson’s
Charity Parkinson’s UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson’s and slow down the progression of the condition. Building on recent discoveries that show a direct link between mitochondrial dysfunction and the loss of dopamine cells, Parkinson’s UK will […]